Fatimah Alahmari

Dr. Fatimah Alahmari

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 June 2019 in Metabolites
Verified
Journal Article
Open access
PDF file
AEAbdul-Hamid Emwas
Abdul-Hamid Emwas
RRRaja Roy
Raja Roy
Ryan McKayRyan McKay
Ryan McKay
Leonardo TenoriLeonardo Tenori
Leonardo Tenori
Edoardo SaccentiEdoardo Saccenti
Edoardo Saccenti
David Scott WishartDavid Scott Wishart
David Scott Wishart
Over the past two decades, nuclear magnetic resonance (NMR) has emerged as one of the three principal analytical techniques used in metabolomics (the other two being gas chromatography coupled to mass spectrometry (GC-MS) and liquid chromatography coupled with single-stage mass spectrometry (LC-MS)). The relative ease of sample preparation, the ability to quantify metabolite levels, the high level of experimental reproducibility, and the inherently nondestructive nature of NMR spectroscopy have made it the preferred platform for long-term or large-scale clinical metabolomic studies. These advantages, however, are often outweighed by the fact that most other analytical techniques, including both LC-MS and GC-MS, are inherently more sensitive than NMR, with lower limits of detection typically being 10 to 100 times better. This review is intended to introduce readers to the field of NMR-based metabolomics and to highlight both the advantages and disadvantages of NMR spectroscopy for metabolomic studies. It will also explore some of the unique strengths of NMR-based metabolomics, particularly with regard to isotope selection/detection, mixture deconvolution via 2D spectroscopy, automation, and the ability to noninvasively analyze native tissue specimens. Finally, this review will highlight a number of emerging NMR techniques and technologies that are being used to strengthen its utility and overcome its inherent limitations in metabolomic applications.

1 May 2020 in Journal of Materials Research and Technology
Verified
Journal Article
Open access
NAN.A. Algarou
N.A. Algarou
Yassine SlimaniYassine Slimani
Yassine Slimani
MAM.A. Almessiere
M.A. Almessiere
FAFatimah Alahmari
Fatimah Alahmari
MVM.G. Vakhitov
M.G. Vakhitov
ABA. Baykal
A. Baykal

9 October 2020 in Molecules
Verified
Journal Article
Open access
PDF file
AEAbdul-Hamid Emwas
Abdul-Hamid Emwas
KSKacper Szczepski
Kacper Szczepski
MJMariusz jaremko
Mariusz jaremko
KCkousik chandra
kousik chandra
Ryan McKayRyan McKay
Ryan McKay
MJMariusz jaremko
Mariusz jaremko
Studying disease models at the molecular level is vital for drug development in order to improve treatment and prevent a wide range of human pathologies. Microbial infections are still a major challenge because pathogens rapidly and continually evolve developing drug resistance. Cancer cells also change genetically, and current therapeutic techniques may be (or may become) ineffective in many cases. The pathology of many neurological diseases remains an enigma, and the exact etiology and underlying mechanisms are still largely unknown. Viral infections spread and develop much more quickly than does the corresponding research needed to prevent and combat these infections; the present and most relevant outbreak of SARS-CoV-2, which originated in Wuhan, China, illustrates the critical and immediate need to improve drug design and development techniques. Modern day drug discovery is a time-consuming, expensive process. Each new drug takes in excess of 10 years to develop and costs on average more than a billion US dollars. This demonstrates the need of a complete redesign or novel strategies. Nuclear Magnetic Resonance (NMR) has played a critical role in drug discovery ever since its introduction several decades ago. In just three decades, NMR has become a “gold standard” platform technology in medical and pharmacology studies. In this review, we present the major applications of NMR spectroscopy in medical drug discovery and development. The basic concepts, theories, and applications of the most commonly used NMR techniques are presented. We also summarize the advantages and limitations of the primary NMR methods in drug development.

3 September 2020 in Antibiotics
Verified
Journal Article
Open access
PDF file
MOHAMMAD AZAM ANSARIMOHAMMAD AZAM ANSARI
MOHAMMAD AZAM ANSARI
HANI ALBETRANHANI ALBETRAN
HANI ALBETRAN
MAMuidh Alheshibri
Muidh Alheshibri
ATAbdelmajid Timoumi
Abdelmajid Timoumi
NANorah Abdullah Algarou
Norah Abdullah Algarou
It-Meng (Jim) LowIt-Meng (Jim) Low
It-Meng (Jim) Low
Recently, titanium dioxide (TiO2) nanomaterials have gained increased attention because of their cost-effective, safe, stable, non-toxic, non-carcinogenic, photocatalytic, bactericidal, biomedical, industrial and waste-water treatment applications. The aim of the present work is the synthesis of electrospun TiO2 nanofibers (NFs) in the presence of different amounts of air–argon mixtures using sol-gel and electrospinning approaches. The physicochemical properties of the synthesized NFs were examined by scanning and transmission electron microscopies (SEM and TEM) coupled with energy-dispersive X-ray spectroscopy (EDX), ultraviolet-visible spectroscopy and thermogravimetric analyzer (TGA). The antibacterial and antibiofilm activity of synthesized NFs against Gram-negative Pseudomonas aeruginosa and Gram-positive methicillin-resistant Staphylococcusaureus (MRSA) was investigated by determining their minimum bacteriostatic and bactericidal values. The topological and morphological alteration caused by TiO2 NFs in bacterial cells was further analyzed by SEM. TiO2 NFs that were calcined in a 25% air-75% argon mixture showed maximum antibacterial and antibiofilm activities. The minimum inhibitory concentration (MIC)/minimum bactericidal concentration (MBC) value of TiO2 NFs against P. aeruginosa was 3 and 6 mg/mL and that for MRSA was 6 and 12 mg/mL, respectively. The MIC/MBC and SEM results show that TiO2 NFs were more active against Gram-negative P. aeruginosa cells than Gram-positive S. aureus. The inhibition of biofilm formation by TiO2 NFs was investigated quantitatively by tissue culture plate method using crystal violet assay and it was found that TiO2 NFs inhibited biofilm formation by MRSA and P. aeruginosa in a dose-dependent manner. TiO2 NFs calcined in a 25% air-75% argon mixture exhibited maximum biofilm formation inhibition of 75.2% for MRSA and 72.3% for P. aeruginosa at 2 mg/mL, respectively. The antibacterial and antibiofilm results suggest that TiO2 NFs can be used to coat various inanimate objects, in food packaging and in waste-water treatment and purification to prevent bacterial growth and biofilm formation.

1 October 2020 in Materials Chemistry and Physics
Verified
Journal Article
Closed access
Yassine SlimaniYassine Slimani
Yassine Slimani
MAM.A. Almessiere
M.A. Almessiere
SGS. Guner
S. Guner
FAFatimah Alahmari
Fatimah Alahmari
GYGhulam Yasin
Ghulam Yasin
ABA. Baykal
A. Baykal

10 May 2025 in Metabolomics
Verified
Journal Article
Open access
PDF file
AEAbdul-Hamid Emwas
Abdul-Hamid Emwas
HZHelena U. Zacharias
Helena U. Zacharias
MAMarcos Rodrigo Alborghetti
Marcos Rodrigo Alborghetti
G. A. Nagana GowdaG. A. Nagana Gowda
G. A. Nagana Gowda
DRDaniel Raftery
Daniel Raftery
David Scott WishartDavid Scott Wishart
David Scott Wishart
Background Metabolic profiling of blood metabolites, particularly in plasma and serum, is vital for studying human diseases, human conditions, drug interventions and toxicology. The clinical significance of blood arises from its close ties to all human cells and facile accessibility. However, patient-specific variables such as age, sex, diet, lifestyle and health status, along with pre-analytical conditions (sample handling, storage, etc.), can significantly affect metabolomic measurements in whole blood, plasma, or serum studies. These factors, referred to as confounders, must be mitigated to reveal genuine metabolic changes due to illness or intervention onset. Review objective This review aims to aid metabolomics researchers in collecting reliable, standardized datasets for NMR-based blood (whole/serum/plasma) metabolomics. The goal is to reduce the impact of confounding factors and enhance inter-laboratory comparability, enabling more meaningful outcomes in metabolomics studies. Key concepts This review outlines the main factors affecting blood metabolite levels and offers practical suggestions for what to measure and expect, how to mitigate confounding factors, how to properly prepare, handle and store blood, plasma and serum biosamples and how to report data in targeted NMR-based metabolomics studies of blood, plasma and serum.